Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Pinterest stock jumped late Thursday after the social media company reported fourth quarter results with a strong sales forecast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback